143 related articles for article (PubMed ID: 10512067)
1. Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MAC sevoflurane for 8 hours.
Goldberg ME; Larijani GE; Eger EI
Pharmacotherapy; 1999 Oct; 19(10):1173-6. PubMed ID: 10512067
[TBL] [Abstract][Full Text] [Related]
2. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118
[TBL] [Abstract][Full Text] [Related]
3. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers.
Goldberg ME; Cantillo J; Gratz I; Deal E; Vekeman D; McDougall R; Afshar M; Zafeiridis A; Larijani G
Anesth Analg; 1999 Feb; 88(2):437-45. PubMed ID: 9972771
[TBL] [Abstract][Full Text] [Related]
4. Renal toxicity with sevoflurane: a storm in a teacup?
Gentz BA; Malan TP
Drugs; 2001; 61(15):2155-62. PubMed ID: 11772127
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers.
Eger EI; Koblin DD; Bowland T; Ionescu P; Laster MJ; Fang Z; Gong D; Sonner J; Weiskopf RB
Anesth Analg; 1997 Jan; 84(1):160-8. PubMed ID: 8989018
[TBL] [Abstract][Full Text] [Related]
6. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity.
Kharasch ED; Frink EJ; Zager R; Bowdle TA; Artru A; Nogami WM
Anesthesiology; 1997 Jun; 86(6):1238-53. PubMed ID: 9197292
[TBL] [Abstract][Full Text] [Related]
7. Safety of low-flow sevoflurane anesthesia in patients with chronically impaired renal function is not proven.
Saidman LJ; Eger EI
Anesthesiology; 2003 Sep; 99(3):752; author reply 752-4. PubMed ID: 12960564
[No Abstract] [Full Text] [Related]
8. The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers.
Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
Anesth Analg; 1998 Feb; 86(2):414-21. PubMed ID: 9459259
[TBL] [Abstract][Full Text] [Related]
9. Changing aspects of sevoflurane in paediatric anaesthesia: 1975-99.
Holzki J; Kretz FJ
Paediatr Anaesth; 1999; 9(4):283-6. PubMed ID: 10411761
[No Abstract] [Full Text] [Related]
10. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane.
Higuchi H; Wada H; Usui Y; Goto K; Kanno M; Satoh T
Anesthesiology; 2001 Jan; 94(1):21-31. PubMed ID: 11135718
[TBL] [Abstract][Full Text] [Related]
11. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia.
Bito H; Ikeda K
Anesth Analg; 1996 Jan; 82(1):173-6. PubMed ID: 8712397
[TBL] [Abstract][Full Text] [Related]
12. Sevoflurane degradation product concentrations with soda lime during prolonged anesthesia.
Frink EJ; Isner RJ; Malan TP; Morgan SE; Brown EA; Brown BR
J Clin Anesth; 1994; 6(3):239-42. PubMed ID: 8060632
[TBL] [Abstract][Full Text] [Related]
13. Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison.
Kharasch ED; Jubert C
Anesthesiology; 1999 Nov; 91(5):1267-78. PubMed ID: 10551576
[TBL] [Abstract][Full Text] [Related]
14. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers.
Ebert TJ; Messana LD; Uhrich TD; Staacke TS
Anesth Analg; 1998 Mar; 86(3):662-7. PubMed ID: 9495434
[TBL] [Abstract][Full Text] [Related]
15. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers.
Ebert TJ; Frink EJ; Kharasch ED
Anesthesiology; 1998 Mar; 88(3):601-10. PubMed ID: 9523801
[TBL] [Abstract][Full Text] [Related]
16. Cysteine conjugate beta-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A.
Iyer RA; Frink EJ; Ebert TJ; Anders MW
Anesthesiology; 1998 Mar; 88(3):611-8. PubMed ID: 9523802
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of sevoflurane stability during low flow anesthesia].
Elizarov AIu; Ershov TD; Levshankov AI
Anesteziol Reanimatol; 2011; (2):8-10. PubMed ID: 21688653
[TBL] [Abstract][Full Text] [Related]
18. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia.
Jääskeläinen SK; Kaisti K; Suni L; Hinkka S; Scheinin H
Neurology; 2003 Oct; 61(8):1073-8. PubMed ID: 14581667
[TBL] [Abstract][Full Text] [Related]
19. Epileptiform discharges during 2 MAC sevoflurane anesthesia in two healthy volunteers.
Kaisti KK; Jääskeläinen SK; Rinne JO; Metsähonkala L; Scheinin H
Anesthesiology; 1999 Dec; 91(6):1952-5. PubMed ID: 10598642
[No Abstract] [Full Text] [Related]
20. [Kidney function in test subjects: published results and clinical relevance].
Frink EJ
Anaesthesist; 1998 Nov; 47 Suppl 1():S33-6. PubMed ID: 9893878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
